Skip to main content
SpringerLink
Log in

Neuroendokrinologische un psychoneuroimmunologische Grundlagen psychiatrischer Erkrankungen

  • Chapter
Psychiatrie und Psychotherapie

  • 699 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ader R, Felten DL, Cohen N (1991) Psychoneuroimmunology, 2nd edn. Academic Press, San Diego, New York, Toronto

    Google Scholar 

  • Alonso R, Chaudieu I, Diorio J, Krishnamurthy A, Quirion R, Boksa P (1993) Interleukin-2 modulates evoked release of [3H]dopamine in rat cultured mesencephalic cells. J Neurochem 61:1284–1290

    CAS  PubMed  Google Scholar 

  • Araujo DM, Lapchak PA, Chabot JG, Nair NP, Quirion R (1989) Characterization and possible role of growth factor and lymphokine receptors in the regulation of cholinergic function in the mammalian brain. Prog Clin Biol Res 317:423–436

    CAS  PubMed  Google Scholar 

  • Baker GA, Syntalo R, Blumenstein J (1977) Effects of psychotropic agents upon the blastogenic response on human T-lymphocytes. Biol Psychiatry 12:159–169

    CAS  PubMed  Google Scholar 

  • Bardeleben U von, Stalla GK, Müller OA, Holsboer F (1988) Blunting of corticotropin response to corticotropin-releasing hormone in depressed patients is avoided by metyrapone pretreatment. Biol Psychiatry 24:782–786

    Article  Google Scholar 

  • Baulieu EE (1991) Neurosteroids: A new function in the brain. Biol Cell 71:3–10

    Article  CAS  PubMed  Google Scholar 

  • Behl C, Skutella T, Lezoualc’h F, Post A, Widmann M, Newton C, Holsboer F (1997) Neuroprotection of against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 51:535–541

    CAS  PubMed  Google Scholar 

  • Benveniste EN (1992) Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 263 (Cell Physiol 32):C1–C16

    CAS  PubMed  Google Scholar 

  • Berrios GE, Quemada JI (1990) Depressive illness in multiple sclerosis. Clinical and theoretical aspects of the association. Br J Psychiatry 156:10–16

    CAS  PubMed  Google Scholar 

  • Bertini S, Garattini R, Delgado P, Ghezzi P (1993) Pharmacological activities of chlorpromazine involved in the inhibition of tumour necrosis factor production in vivo in mice. Immunology 79:217–219

    CAS  PubMed  Google Scholar 

  • Besedovsky HO, Del Ray A, Sorkin E, Dinarello CA (1986) Immunregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233:652–654

    CAS  PubMed  Google Scholar 

  • Brady LS, Whitfield HJ, Fox RJ, Gold PW, Herkenham M (1991) Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. J Clin Invest 87:831–837

    CAS  PubMed  Google Scholar 

  • Brockington IF, Meakin CJ (1994) Clinical clues to the aetiology of puerperal psychosis. Prog Neuropsychopharmacol Biol Psychiatry 18:417–429

    Article  CAS  PubMed  Google Scholar 

  • Boukhris W, Kouassi E, Revillard JP (1988) Differential effect of mixed D1/D2 and selective D2 dopaminergic antagonists on mouse T and B lymphocyte proliferation and interleukin production in vitro. Immunopharmacol Immunotoxicol 10:501–512

    CAS  PubMed  Google Scholar 

  • Bruce LC, Peebles AMS (1903) Clinical and experimental observations on catatonia. J Ment Sci 49:614–628

    Google Scholar 

  • Carroll BJ (1982) The dexamethasone suppression test for melancholia. Br J Psychiatry 140:292–304

    CAS  PubMed  Google Scholar 

  • Checkley SA, Wieck A, Marks M, Kumar R, Bearn JA, Campbell I (1992) Neuroendocrine studies of the aetiology of puerperal psychosis. Clin Neuropharmacol 15:212–213

    Google Scholar 

  • Dameshek W (1930) White blood cells in dementia praecox and dementia paralytietwa. Arch Neurol Psychiatry 24:855

    Google Scholar 

  • DeLisi LE, Goodman S, Neckers LM, Wyatt RJ (1982) An analysis of lymphocyte subpopulations in schizophrenic patients. Biol Psychiatry 17:1003–1009

    CAS  PubMed  Google Scholar 

  • DeLisi LE, Weber RJ, Pert CB (1985) Are there antibodies against brain in sera from schizophrenic patients? Biol Psychiatry 20:94–119

    Article  Google Scholar 

  • Denny DR, Stephenson LA, Penick EC, Weller RA (1988) Lymphocyte subclasses and depression. J Abnormal Psychol 97:499–502

    Google Scholar 

  • Denicoff KD, Rubinoff DR, Papa MZ et al. (1987) The neuropsychiatric effects of treatment with Interleukin-2 and lymphokine-activated killer cells. Ann Internal Med 107:293–300

    CAS  Google Scholar 

  • Earle BV (1970) Thyroid hormone and tricyclic antidepressants in resistant depressions. Am J Psychiatry 126:143–145

    Google Scholar 

  • Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240:889–895

    CAS  PubMed  Google Scholar 

  • Flood JF, Smith GE, Roberts E (1988) Dehydroepiandrosterone and its sulfate enhance memory retention in mice. Brain Res 447:269–278

    Article  CAS  PubMed  Google Scholar 

  • Frenzel KH, Müller N, Heidmann D, Hampel H, Kretzschmar HA, Penning R, Ackenheil M (1995) Expression of T cell receptor gd antigens in human brain tissue. Neuro Immunomodulation 2:115–120

    CAS  Google Scholar 

  • Friess E, Trachsel L, Guldner J, Schier T, Steiger A, Holsboer F (1995) DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range. Am J Physiol 268:E107–E113

    CAS  PubMed  Google Scholar 

  • Friess E, Tagaya H, Trachsel L, Holsboer F, Rupprecht R (1997) Progesterone-induced changes in sleep in male subjects. Am J Physiol 272:E885–E891

    CAS  PubMed  Google Scholar 

  • Ganguli R, Rabin BS (1989) Increased serum Interleukin 2 receptor levels in schizophrenic and brain damaged subjects. Arch Gen Psychiatry 46:292

    CAS  PubMed  Google Scholar 

  • Ganguli R, Brar JS, Chengappa KR, DeLeo M, Yang ZW, Shurin G, Rabin B (1995) Mitogen-stimulated interleukin 2 production in never-medicated, first episode schizophrenics — the influence of age of onset and negative symptoms. Arch Gen Psychiatry 52:668–672

    CAS  PubMed  Google Scholar 

  • Ghadirian AM, Engelsmann F, Dhar V, Filipi D, Keller R, Chouinard G, Murphy BEP (1995) The psychotropic effects of inhibitors of steroid biosynthesis in depressed patients refractory to treatment. Biol Psychiatry 37:369–375

    CAS  PubMed  Google Scholar 

  • Gold PW, Loriaux DL, Roy A et al. (1986) Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing’s disease. N Engl J Med 314:1329–1335

    CAS  PubMed  Google Scholar 

  • Gregoire AJP, Kumar R, Everitt B, Henderson AF, Studd JWW (1996) Transdermal oestrogen for treatment of severe postnatal depression. Lancet 347:930–933

    Article  CAS  PubMed  Google Scholar 

  • Großkopf A, Müller N, Malo A, Wank R (1998) Potential role for the narcolepsy-and multiple sclerosis-associated allele DQB1 *0602 in schizophrenia subtypes. Schizophr Res 30:187–189

    Article  PubMed  Google Scholar 

  • Häfner H, Nowotny B (1995) Epidemiology of early-onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 245:80–92

    PubMed  Google Scholar 

  • Hampel H, Schwarz MJ, Kötter HU, Schneider C, Müller N (1996) Cell adhesion molecules in the central nervous system: significance and therapeutic perspecitves in neuropsychiatric disorders. Drug News & Perspectives 9:69–81

    CAS  Google Scholar 

  • Henneberg A, Riedl B, Dumke HO, Kornhuber HH (1990) T-lymphocyte subpopulations in schizophrenic patients. Eur Arch Psychiatr Neurol Sci 239:283–284

    Article  CAS  Google Scholar 

  • Holsboer F, Barden N (1996) Antidepressants and hypothalamicpituitary-adrenocortical regulation. Endoc Rev 17:187–205

    CAS  Google Scholar 

  • Holsboer F, Liebl R, Hofschuster E (1982) Repeated dexamethasone suppression test during depressive illness. Normalization of test result compared with clinical improvement. J Affect Disord 4:93–101

    Article  CAS  PubMed  Google Scholar 

  • Holsboer F, von Bardeleben U, Gerken A, Stalla GK, Müller OA (1984) Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. N Engl J Med 311:1127

    CAS  PubMed  Google Scholar 

  • Holsboer F, Wiedemann K, Boll E (1986) Shortened dexamethasone half-life time in depressed nonsuppressors. Arch Gen Psychiatry 43:813–815

    CAS  PubMed  Google Scholar 

  • Holsboer F, von Bardeleben U, Wiedemann K, Müller OA, Stalla GK (1987) Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression-implications for pathophysiology of DST nonsuppression. Biol Psychiatry 22:228–234

    Article  CAS  PubMed  Google Scholar 

  • Hornberg M, Arolt V, Wilke I, Kruse A, Kirchner H (1995) Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia. Schizophrenia Res 15:237–242

    CAS  Google Scholar 

  • Hudson JI, Hudson MS (1984) Endocrine dysfunction in anorexia nervosa and bulimia: comparison with abnormalities in other psychiatric disorders and disturbances due to metabolic factors. Psychiatr Dev 2:237–272

    CAS  PubMed  Google Scholar 

  • Irwin MR, Smith TL, Gillin C (1987) Reduced natural killer cytotoxity in depressed patients. Life Sci 41:2127–2133

    Article  CAS  PubMed  Google Scholar 

  • Kellner M, Herzog L, Yassouridis A, Holsboer F, Wiedemann K (1995) Possible role of atrial natriuretic hormoe in pituitary adrenocortical unresponsiveness in lactate-induced panic. Am J Psychiatry 152:1365–1367

    CAS  PubMed  Google Scholar 

  • Knight JG (1982) Dopamine-receptor-stimulating autoantibodies, a possible cause of schizophrenia. Lancet i:1073–1076

    Google Scholar 

  • Krieg J-C, Lauer CJ, Hermle L, von Bardeleben U, Pollmächer T, Holsboer F (1990) Psychometric, polysomnographic, and neuroendocrine measures in subjects at high risk for psychiatric disorders. Neuropsychobiology 23:57–67

    CAS  PubMed  Google Scholar 

  • Kurtz g, Müller N (1994) The antiphospholipid syndrome and psychosis. Am J Psychiatry 151:1841–1842

    CAS  PubMed  Google Scholar 

  • Lancel M, Faulhaber J, Holsboer F, Rupprecht R (1996) Progesterone induces changes in sleep EEG comparable to those of agonistic GABAA receptor modulators. Am J Physiol 271:E763–E772

    CAS  PubMed  Google Scholar 

  • Lapchak PA (1992) A role for Interleukin-2 in the regulation of striatal dopaminergic function. Neuroreport 3:165–168

    CAS  PubMed  Google Scholar 

  • Lehmann-Facius H (1939) Serologisch-analytische Versuche mit Liquores und Seren von Schizophrenen. Allg Z Psychiatrie 110:232–243

    Google Scholar 

  • Lesch KP, Rupprecht R (1989) Psychoneuroendocrine research in depression: II. Hormonal responses to releasing hormones as a probe for hypothalamic-pituitary-endorgan dysfunction. J Neural Transm 75:179–194

    CAS  PubMed  Google Scholar 

  • Lesch KP, Rupprecht R, Müller U, Pfüller H, Beckmann H (1988) Insulin-like growth factor I in depression. Acta Psychiatr Scand 78:684–688

    CAS  PubMed  Google Scholar 

  • Lesch KP, Ihl R, Frölich L, Rupprecht R, Müller U, Schulte HM, Maurer K (1990) Endocrine responses to growth hormone releasing hormone and corticotropin releasing hormone in early onset Alzheimer’s disease. Psychiatry Res 33:107–112

    CAS  PubMed  Google Scholar 

  • Levy EM, Borrelli DJ, Mirin SM et al. (1991) Biological measures and cellular immunological function in depressed psychiatric inpatients. Psychiatry Res 36:157–167

    Article  CAS  PubMed  Google Scholar 

  • Lewandowski G, Hobbs MV, Blomom FE (1994) Alteration of intracerebral cytokine production in mice infected with herpes simplex virus types 1 and 2. J Neuroimmunol 55:2334

    Article  Google Scholar 

  • Licinio J, Seibyl, JP, Altemus M, Charney DS, Krystal JH (1993) Elevated levels of Interleukin-2 in neuroleptic-free schizophrenics. Am J Psychiatry 150:1408–1410

    CAS  PubMed  Google Scholar 

  • Lieberman AP, Pitha PM, Shin HS, Shin ML (1989) Produktion of Tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci U S A 86:6348–6352

    CAS  PubMed  Google Scholar 

  • Linkowski P, Mendlewicz J, Kerkhofs M et al. (1987) 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J Clin Endocrinol Metab 65:141–152

    CAS  PubMed  Google Scholar 

  • Linnoila M, Cowdry R, Bror-Axel L, Makinen T, Rubinow D (1983) CSF triiodothyronine (rT3) levels in patients with affective disorders. Biol Psychiatry 18:1489–1492

    CAS  PubMed  Google Scholar 

  • Loosen PT, Prange AJ (1982) Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review. Am J Psychiatry 139:405–416

    CAS  PubMed  Google Scholar 

  • McAllister CG, Rapaport MH, Pickar D, Podruchny TA, Christison G, Alphs LD, Paul SM (1989a) Increased number of CD5+ B-lymphocytes in schizophrenic patients. Arch Gen Psychiatry 46:890–894

    CAS  PubMed  Google Scholar 

  • McAllister CG, Rapaport MH, Pickar D, Paul SM (1989b) Effect of short term administration of antipsychotic drugs on lymphocyte subsets in schizophrenic patients. Arch Gen Psychiatry 46:956–957

    CAS  PubMed  Google Scholar 

  • McAllister CG, van Kammen DP, Rehn TJ et al. (1995) Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status. Am J Psychiatry 152:1291–1297

    CAS  PubMed  Google Scholar 

  • Maes M (1995) Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 19:11–38

    Article  CAS  PubMed  Google Scholar 

  • Maes M, Meltzer HY, Bosmans E (1994) Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine. Acta Psychiatr Scand 89:346–351

    CAS  PubMed  Google Scholar 

  • Maes M, Bosmans E, Meltzer HY (1995a) Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol. Eur Arch Psychiatry Clin Neurosci 245:172–178

    Article  CAS  PubMed  Google Scholar 

  • Maes M, Smith R, Scharpe S (1995b) The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinol 20:111–116

    CAS  Google Scholar 

  • Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY (1996) Interleukin-2 and Interleukin-6 in schizophrenia and mania: effects of neuroleptics and moodstabilizers. J Psychiatr Res 29:141–152

    Google Scholar 

  • Merill JE (1992) Tumor necrosis factor alpha, Interleukin 1 and related cytokines in brain development: normal and pathological. Dev Neurosci 14:1–10

    Google Scholar 

  • Miller, AH, Lackner C (1989) Tricyclic antidepressants and immunity. In: Miller AH (ed) Depressive disorders and immunity. Am. Psychiat Press, Washington, pp 85–103

    Google Scholar 

  • Müller N (1995) Psychoimmunology: Implications for the drug treatment of psychiatric disorders. CNS Drugs 4:125140

    Google Scholar 

  • Müller N, Ackenheil M (1995a) Immunoglobulin and albumin contents of cerebrospinal fluid in schizophrenic patients: The relationship to negative symptomatology. Schizophr Res 14:223–228

    Article  PubMed  Google Scholar 

  • Müller N, Ackenheil M (1995b) The immune system and schizophrenia. In: Leonard BE, Miller K (eds) Stress, the immune system and psychiatry. Wiley & Sons, New York Chichester, pp 137–164

    Google Scholar 

  • Müller N, Ackenheil M (1998) Psychoneuroimmunology, the cytokine network in the CNS, and the implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 22:1–31

    Article  PubMed  Google Scholar 

  • Müller N, Ackenheil M, Eckstein R, Hofschuster E, Mempel W (1987) Reduced suppressor cell function in psychiatric patients. Ann N Y Acad Sci 496:686–690

    PubMed  Google Scholar 

  • Müller N, Ackenheil M, Hofschuster E, Mempel W, Eckstein R (1991) Cellular immunityin schizophrenic patients before and during neuroleptic therapy. Psychiatry Res 37:147–160

    Article  PubMed  Google Scholar 

  • Müller N, Gizycki-Nienhaus B, Günther W, Meurer M (1992) Depression as a possible cerebral manifestation of scleroderma: immunological findings in serum and CSF. Biol Psychiatry 31:1151–1156

    Article  PubMed  Google Scholar 

  • Müller N, Empel M, Riedel M, Schwarz M, Ackenheil M (1997) Increase of soluble IL-2 receptors levels and decrease of soluble IL-6 receptors levels reflect the immunmodulatory effect of neuroleptics. Eur Arch Psychiatry Clin Neursci 247:308–313

    Google Scholar 

  • Murphy BEP, Dhar V, Ghadirian AM, Chouinard G, Keller R (1991) Response to steroid suppression in major depression resistant to antidepressant therapy. J Clin Psychopharmacol 11:121–126

    CAS  PubMed  Google Scholar 

  • Nemeroff CB, Widerlöv E, Bisette G et al. (1984) Elevated concentrations of CSF corticotropin-releasing-factor-like immunoreactivity in depressed patients. Science 226:1342–1343

    CAS  PubMed  Google Scholar 

  • Nemni R, Iannaccone S, Quattrini A et al. (1992) Effect of chronic treatment with recombinant interleukin-2 on the central nervous system of adult and old mice. Brain Res 591:248–252

    Article  CAS  PubMed  Google Scholar 

  • Neuhauser H, Laakmann G (1988) Stimulation of growth hormone by GHRH as compared to DMI in depressed patients. Pharmacopsychiatry 21:443–444.

    CAS  PubMed  Google Scholar 

  • Nisticò G, De Sarro G (1991) Is Interleukin 2 a neuromodulator in the brain? Trends Pharmacol Sci 14:146–150

    Google Scholar 

  • Norris JG, Benveniste EN (1993) Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine. J Neuroimmunol 45:137–146

    CAS  PubMed  Google Scholar 

  • O’Dwyer A-M, Lightman SL, Marks MN, Checkley SA (1995) Treatment of major depression with metyrapone and hydrocortisone. J Affect Disord 33:123–128

    CAS  PubMed  Google Scholar 

  • Paul SM, Purdy RH (1992) Neuroactive steroids. FASEB J 6:2311–2322

    CAS  PubMed  Google Scholar 

  • Pennisi E (1997) Neuroimmunology. Tracing molecules that make the brain-body connection. Science 275:930–931

    CAS  PubMed  Google Scholar 

  • Plata-Salaman CR (1991) Immunoregulators in the nervous system. Neurosci Biobehav Rev 15:185–215

    CAS  PubMed  Google Scholar 

  • Pollmächer T, Hinze-Selch D, Mullington J, Holsboer F (1995) Clozapine-induced increase in plasma levels of soluble Interleukin-2 receptors. Arch Gen Psychiatry 52:877–878

    PubMed  Google Scholar 

  • Rao ML, Strebel B, Halaris A, Gross G, Braunig P, Huber G, Marler M (1995) Circadian rhythm of vital signs, norepinephrine, epinephrine, thyroid hormones, and cortisol in schizophrenia. Psychiatry Research 57:21–39

    Article  CAS  PubMed  Google Scholar 

  • Rapaport MH, McAllister CG, Pickar D, Nelson DM, Paul SM (1989) Elevated levels of soluble interleukin 2 receptors in schizophrenia. Arch Gen Psychiatry 46:292

    Google Scholar 

  • Rupprecht R, Holsboer F (1999) Neuroactive steroids:mechanisms of action and neuropharmacological perspectives. Trends in Neurosciences 22:410–416

    Article  CAS  PubMed  Google Scholar 

  • Rupprecht R, Lesch KP (1989) Psychoneuroendocrine research in depression: I. Hormone levels of different neuroendocrine axes and the dexamethasone suppression test. J Neural Transm 75:167–178

    Article  CAS  PubMed  Google Scholar 

  • Rupprecht R, Lesch KP, Müller U, Beck G, Beckmann H, Schulte HM (1989a) Blunted adrenocorticotropin but normal ß-endorphin release after human corticotropin-releasing hormone administration in depression. J Clin Endocrinol Metab 69:600–603

    CAS  PubMed  Google Scholar 

Download references

Authors
  1. R. Rupprecht
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Psychiatrie und Psychotherapie, Klinikum der Ludwig-Maximilians-Universität München, Nußbaumstraße 7, 80336, München

    Hans-Jürgen Möller  & Hans-Peter Kapfhammer  & 

  2. Bezirksklinikum Gabersee, Fachkrankenhaus für Psychiatrie Psychotherapie und Neurologie, Gabersee 7, 83512, Wasserburg a. Inn

    Gerd Laux

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Rupprecht, R., Müller, N. (2003). Neuroendokrinologische un psychoneuroimmunologische Grundlagen psychiatrischer Erkrankungen. In: Möller, HJ., Laux, G., Kapfhammer, HP. (eds) Psychiatrie und Psychotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27386-7_7

Download citation

  • DOI: https://doi.org/10.1007/3-540-27386-7_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-25074-6

  • Online ISBN: 978-3-540-27386-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation